Our Partnerships
We are delighted to be collaborating with a wide range of UK universities, research centres, private companies and trusts and are excited to continue to expand our network within the UK.
Why work across borders?
The Institut Pasteur is an international centre of excellence for biomedical research, producing globally recognised leading research in the fields of infectious disease, microbiology and immunology, amongst other public health areas. In the UK, there are many institutions with complementary expertise, studying the same research areas as the Institut Pasteur but from slightly different scientific angles. Our Partnerships allow our scientists on both sides of the Channel to develop cutting- edge projects at the interface of multiple scientific disciples to tackle some of the greatest threats to public health, together.
Current projects
Here are a few examples of how that interdisciplinary cross- boarder collaboration works in practice.
Oxford - Pasteur Joint PhD Programme
Antimicrobial resistance (AMR) is dramatically increasing worldwide, becoming one of the most urgent public health threats. If we don't find ways to combat AMR, everyday procedures like having a filling or giving birth could become life threatening. There is a pressing need to reverse the spread of AMR pathogens and to develop innovative drugs (antibiotics, anti-parasites, antifungals, antivirus) and therapeutic strategies as sustainable treatments of infectious diseases.
Our joint PhD programme with the University of Oxford offers students the opportunity to tackle collaborative projects between the Institut Pasteur and the Oxford Chemistry Department to fight AMR, learning from scientists at Pasteur who specialise in biomedical research and researchers at Oxford who focus on combating antibiotic resistance.
The Francis Crick Institute
The link between neurology and immunology has been increasingly gaining traction in recent years. Institut Pasteur scientists have been focused on neurodegenerative diseases, and brain connectivity disorders, in particular exploring interdisciplinary causes through newer disciplines such as neroimmunology. In 2019, the Institut Pasteur hosted scientists from the Crick and Pasteur for their first joint workshop on Neuroimmunology. In June 2023, the Francis Crick Institute hosted scientists from the Crick and the Institut Pasteur in a Neuro-Immune symposium, bringing together leaders in the fields of neurology and immunology to explore some of the most pressing issues in the study of the human brain. The two institutes have since signed an MoU and continue to work together.
London School of Hygiene and Tropical Medicine
Scientists at the Institut Pasteur have partnered with the London School of Hygiene and Tropic Medicine on a project to identify and treat malaria infected people, before they develop symptoms, in order to prevent further transmission. This project is focused on a particularly dangerous strain of malaria named P. vivax. Until now, P.Vivax has been successful at resisting elimination efforts due to its dormant liver forms ('hyponzoites'). These forms cannot be detected with traditional methods but can reactivate 'relapse infection', causing illness and new transmission from people to mosquitos. The project has already developed diagnostic tests to identify people likely to carry hyponzoites and treat them to prevent a relapse.
Other Partnerships
In addition to the projects we are currently focusing on, our researchers also have ongoing collaborations with the following British institutions...
